Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis.

Azimi, Amirreza

Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis. [electronic resource] - Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Jan 2020 - 129-134 p. digital

Publication Type: Journal Article; Meta-Analysis; Systematic Review

1532-2653

10.1016/j.jocn.2019.08.103 doi


Adult
Antibodies, Viral--blood
Female
Humans
Immunologic Factors--adverse effects
Incidence
JC Virus--immunology
Male
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Natalizumab--adverse effects
Seroconversion--drug effects